ID ING2_MOUSE Reviewed; 281 AA. AC Q9ESK4; Q80VI5; Q8BGU8; DT 15-FEB-2005, integrated into UniProtKB/Swiss-Prot. DT 15-FEB-2005, sequence version 2. DT 25-JAN-2012, entry version 99. DE RecName: Full=Inhibitor of growth protein 2; DE AltName: Full=Inhibitor of growth 1-like protein; DE AltName: Full=p33ING2; GN Name=Ing2; Synonyms=Ing1l; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Nagashima M., Hagiwara K., Hancock A.R., Harris C.C.; RL Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Cerebellum, and Hippocampus; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N-3; TISSUE=Mammary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP STRUCTURE BY NMR OF 205-262. RG RIKEN structural genomics initiative (RSGI); RT "Solution structure of PHD domain of inhibitor of growth family, RT member 1-like."; RL Submitted (NOV-2004) to the PDB data bank. CC -!- FUNCTION: Seems to be involved in p53/TP53 activation and CC p53/TP53-dependent apoptotic pathways, probably by enhancing CC acetylation of p53/TP53. Component of a mSin3A-like corepressor CC complex, which is probably involved in deacetylation of CC nucleosomal histones. ING2 activity seems to be modulated by CC binding to phosphoinositides (PtdInsPs) (By similarity). CC -!- SUBUNIT: Interacts with H3K4me3 and to a lesser extent with CC H3K4me2 (By similarity). Component of a mSin3A-like complex at CC least consisting of SIN3A, HDAC1, HDAC2, RBBP4/RbAp48, CC RBBP7/RbAp46, SAP30 and ING2 (By similarity). CC -!- SUBCELLULAR LOCATION: Nucleus (By similarity). Note=Predominantly CC cytoplasmic. Localized to chromatin and nuclear matrix. Upon CC reduced PtdIns(5)P levels seems to be released from chromatin and, CC at least partially, translocated to the cytoplasm (By similarity). CC -!- DOMAIN: The PHD-type zinc finger mediates the binding to H3K4me3 CC (By similarity). CC -!- DOMAIN: The polybasic region (PBR) is responsive to the binding to CC phosphoinositides (PtdInsPs), including phosphatidylinositol 5- CC phosphate (PtdIns(5)P) (By similarity). CC -!- SIMILARITY: Belongs to the ING family. CC -!- SIMILARITY: Contains 1 PHD-type zinc finger. CC -!- SEQUENCE CAUTION: CC Sequence=AAH50003.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF078834; AAG12173.1; -; mRNA. DR EMBL; AK048800; BAC33461.1; -; mRNA. DR EMBL; AK083144; BAC38783.1; -; mRNA. DR EMBL; BC050003; AAH50003.1; ALT_SEQ; mRNA. DR IPI; IPI00308151; -. DR RefSeq; NP_075992.2; NM_023503.3. DR UniGene; Mm.430733; -. DR PDB; 1WES; NMR; -; A=205-262. DR PDB; 2G6Q; X-ray; 2.00 A; A=205-264. DR PDBsum; 1WES; -. DR PDBsum; 2G6Q; -. DR ProteinModelPortal; Q9ESK4; -. DR SMR; Q9ESK4; 212-263. DR MINT; MINT-1340342; -. DR STRING; Q9ESK4; -. DR PRIDE; Q9ESK4; -. DR GeneID; 69260; -. DR KEGG; mmu:69260; -. DR CTD; 3622; -. DR MGI; MGI:1916510; Ing2. DR GeneTree; ENSGT00550000074538; -. DR HOGENOM; HBG716496; -. DR HOVERGEN; HBG006607; -. DR InParanoid; Q9ESK4; -. DR OrthoDB; EOG42RD87; -. DR NextBio; 328987; -. DR ArrayExpress; Q9ESK4; -. DR Bgee; Q9ESK4; -. DR CleanEx; MM_ING2; -. DR Genevestigator; Q9ESK4; -. DR GermOnline; ENSMUSG00000063049; Mus musculus. DR GO; GO:0016580; C:Sin3 complex; ISS:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0016568; P:chromatin modification; IMP:BHF-UCL. DR GO; GO:0048133; P:male germ-line stem cell division; IMP:BHF-UCL. DR GO; GO:0007141; P:male meiosis I; IMP:BHF-UCL. DR GO; GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL. DR GO; GO:0045893; P:positive regulation of transcription, DNA-dependent; IDA:MGI. DR GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW. DR GO; GO:0072520; P:seminiferous tubule development; IMP:BHF-UCL. DR GO; GO:0030317; P:sperm motility; IMP:BHF-UCL. DR GO; GO:0007286; P:spermatid development; IMP:BHF-UCL. DR GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW. DR InterPro; IPR024610; ING_N. DR InterPro; IPR019786; Zinc_finger_PHD-type_CS. DR InterPro; IPR011011; Znf_FYVE_PHD. DR InterPro; IPR001965; Znf_PHD. DR InterPro; IPR019787; Znf_PHD-finger. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR Gene3D; G3DSA:3.30.40.10; Znf_RING/FYVE/PHD; 1. DR Pfam; PF12998; ING; 1. DR Pfam; PF00628; PHD; 1. DR SMART; SM00249; PHD; 1. DR SUPFAM; SSF57903; FYVE_PHD_ZnF; 1. DR PROSITE; PS01359; ZF_PHD_1; 1. DR PROSITE; PS50016; ZF_PHD_2; 1. PE 1: Evidence at protein level; KW 3D-structure; Chromatin regulator; Coiled coil; Complete proteome; KW Growth regulation; Metal-binding; Nucleus; Reference proteome; KW Transcription; Transcription regulation; Zinc; Zinc-finger. FT CHAIN 1 281 Inhibitor of growth protein 2. FT /FTId=PRO_0000212664. FT ZN_FING 213 262 PHD-type. FT REGION 265 281 PBR (By similarity). FT COILED 49 101 Potential. FT BINDING 215 215 Histone H3K4me3 (By similarity). FT BINDING 226 226 Histone H3K4me3 (By similarity). FT BINDING 230 230 Histone H3K4me3 (By similarity). FT BINDING 238 238 Histone H3K4me3 (By similarity). FT CONFLICT 26 26 T -> S (in Ref. 2; BAC33461/BAC38783). FT CONFLICT 72 72 K -> E (in Ref. 1; AAG12173). FT CONFLICT 104 104 I -> N (in Ref. 1; AAG12173). FT CONFLICT 110 110 E -> G (in Ref. 1; AAG12173). FT CONFLICT 116 116 A -> S (in Ref. 1; AAG12173). FT CONFLICT 203 203 P -> S (in Ref. 1; AAG12173). FT CONFLICT 250 250 P -> H (in Ref. 1; AAG12173). FT TURN 216 219 FT STRAND 224 228 FT STRAND 238 240 FT HELIX 242 244 FT HELIX 257 260 SQ SEQUENCE 281 AA; 32992 MW; CDC53B50492C2D8B CRC64; MLGQQQQQQL YSSAALLTGE RSRLLTCYVQ DYLECVESLP HDMQRNVSVL RELDNKYQET LKEIDDVYEK YKKEDDSNQK KRLQQHLQRA LINSQELGDE KIQIVTQMLE LVENRARQME LHSQCFQDPA ESERASDKSK MDSSQPERSS RRPRRQRTSE SRDLCHMTNG IDDCDDQPPK EKRSKSAKKK KRSKAKQERE ASPVEFAIDP NEPTYCLCNQ VSYGEMIGCD NEQCPIEWFH FSCVSLTYKP KGKWYCPKCR GDNEKTMDKS TEKTKKERRA R //